European perspective of perampanel response in people with Intellectual Disability.

Jon AllardWilliam HenleyFrancesca M Snoeijen-SchouwenaarsJans van OolI Y TanH Jurgen SchelhaasMarian H J M MajoieSharon HudsonBrendan McLeanRichard Laugharne

Published in: Acta neurologica Scandinavica (2020)

Comparable rates of seizure reduction are in line with estimates for non-ID patients, adding to the evidence suggesting that PMP has a similar impact on those with ID. Taking a European perspective and sharing data across centres can help strengthen the evidence for prescribing antiepileptic drugs in the ID population.

Keyphrases

intellectual disability
autism spectrum disorder
end stage renal disease
newly diagnosed
ejection fraction
primary care
social media
healthcare
health information
artificial intelligence
temporal lobe epilepsy